Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
Heparin-binding EGF-like growth factor
open-in-new
<h2 id="interactions">Interactions</h2> <p>Heparin-binding EGF-like growth factor has been shown to <a href="/facts/Protein-protein_interaction/etvm9Wmg">interact</a> with <a href="/facts/NRD1/V57n8TBl">NRD1</a>,<a class="footnote-ref" id="fnref:5" href="#fn:5"><sup>5</sup></a> <a href="/facts/Zinc_finger_and_BTB_domain-containing_protein_16/8ScfHtFk">Zinc finger and BTB domain-containing protein 16</a><a class="footnote-ref" id="fnref:6" href="#fn:6"><sup>6</sup></a><a class="footnote-ref" id="fnref:7" href="#fn:7"><sup>7</sup></a> and <a href="/facts/BAG1/VE1afUuC">BAG1</a>.<a class="footnote-ref" id="fnref:8" href="#fn:8"><sup>8</sup></a> </p><p>HB-EGF biological activities with these genes influence cell cycle progression, molecular chaperone regulation, cell survival, cellular functions, adhesion, and mediation of cell migration. The NRD1 gene codes for the protein nardilysin, an HB-EGF modulator.<a class="footnote-ref" id="fnref:9" href="#fn:9"><sup>9</sup></a> Zinc finger and BTB domain-containing protein 16 and BAG family molecular chaperone regulator function as co-chaperone proteins in processes involving HB-EGF. </p> <h2 id="role-in-cancer">Role in cancer</h2> <p>Recent studies indicate significant HB-EGF gene expression elevation in a number of human cancers as well as cancer-derived cell lines. Evidence indicates that HB-EGF plays a significant role in the development of malignant phenotypes contributing to the metastatic and invasive behaviors of tumors.<a class="footnote-ref" id="fnref:10" href="#fn:10"><sup>10</sup></a> The proliferative and chemotactic effects of HB-EGF results from the target influence on particular cells including fibroblasts, smooth muscles cells, and keratinocytes. For numerous cell types such as breast and ovarian tumor cells, human epithelial cells and keratinocytes HB-EGF is a potent mitogen resulting in evidenced upregulation of HB-EGF in such specimens.<a class="footnote-ref" id="fnref:11" href="#fn:11"><sup>11</sup></a> Both in vivo and in vitro studies of tumor formation in cancer derived cell lines indicate that expression of HB-EGF is essential for tumor development. As a result, studies implementing the use of specific HB-EGF inhibitors and <a href="/facts/Monoclonal_antibodies/4rUBWB87">monoclonal antibodies</a> against HB-EGF show the potential for the development of novel therapies for treating cancers by targeting HB-EGF expression.<a class="footnote-ref" id="fnref:12" href="#fn:12"><sup>12</sup></a> </p> <h2 id="role-in-cardiac-development-and-vasculature">Role in cardiac development and vasculature</h2> <p>HB-EGF binding and activation of EGF receptors plays a critical role during cardiac valve tissue development and the maintenance of normal heart function in adults. During valve tissue development the interaction of HB-EGF with EGF receptors and heparan sulfate proteoglycans is essential for the prevention of malformation of valves due to enlargement.<a class="footnote-ref" id="fnref:13" href="#fn:13"><sup>13</sup></a> In the vascular system areas of disturbed flow show upregulation of HB-EGF with promotion of vascular lesions, <a href="/facts/Atherogenesis/WIS8QQ6v">atherogenesis</a>, and hyperplasia of intimal tissue in vessels. The flow disturbance remodeling of the vascular tissues due to HB-EGF expression contributes to aortic valve disease, peripheral vascular disease, and conduit stenosis.<a class="footnote-ref" id="fnref:14" href="#fn:14"><sup>14</sup></a> </p> <h2 id="role-in-wound-healing">Role in wound healing</h2> <p>HB-EGF is the predominant growth factor in the epithelialization required for cutaneous wound healing. The mitogenic and migratory effects of HB-EGF on keratinocytes and fibroblasts promotes dermal repair and <a href="/facts/Angiogenesis/h0HF9IUd">angiogenesis</a> necessary for wound healing and is a major component of wound fluids.<a class="footnote-ref" id="fnref:15" href="#fn:15"><sup>15</sup></a> HB-EGF displays target cell specificity during the early stages of wound healing being released by macrophages, monocytes, and keratinocytes. HB-EGF cell surface binding to heparan sulfate proteoglycans enhances mitogen promoting capabilities increasing the rate of skin wound healing, decreasing human skin graft healing times, and promotes rapid healing of ulcers, burns, and epidermal split thickness wounds.<a class="footnote-ref" id="fnref:16" href="#fn:16"><sup>16</sup></a> </p> <h2 id="role-in-other-physiological-processes">Role in other physiological processes</h2> <p>HB-EGF is recognized as an important component for the modulation of cell activity in various biological interactions. Found widely distributed in cerebral neurons and neuroglia, HB-EGF induced by brain hypoxia and or ischemia subsequently stimulates neurogenesis.<a class="footnote-ref" id="fnref:17" href="#fn:17"><sup>17</sup></a> Interactions between uterine HB-EGF and epidermal growth factor receptors of <a href="/facts/Blastocysts/WkRkxdzc">blastocysts</a> influence embryo-uterine interactions and implantation.<a class="footnote-ref" id="fnref:18" href="#fn:18"><sup>18</sup></a> Studies show HB-EGF protects intestinal stem cells and intestinal epithelial cells in <a href="/facts/Necrotizing_enterocolitis/kfdC3e5f">necrotizing enterocolitis</a>, a disease affecting premature newborns. Associated with a breakdown in gut barrier function, necrotizing enterocolitis may be mediated by HB-EGF effects on intestinal mucosa.<a class="footnote-ref" id="fnref:19" href="#fn:19"><sup>19</sup></a> HB-EGF expressed during skeletal muscle contraction facilitates peripheral glucose removal, glucose tolerance and uptake. The upregulation of HB-EGF with exercise may explain the molecular basis for the decrease in metabolic disorders such as obesity and <a href="/facts/Type_2_diabetes/zCMXksmt">type 2 diabetes</a> with regular exercise.<a class="footnote-ref" id="fnref:20" href="#fn:20"><sup>20</sup></a> </p> <h2 id="further-reading">Further reading</h2> <ul><li>Higashiyama S, Lau K, Besner GE, et al. (1992). <a href="https://doi.org/10.1016%2FS0021-9258%2818%2942682-8">"Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein"</a>. <i>J. Biol. Chem</i>. 267 (9): 6205–12. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0021-9258%2818%2942682-8">10.1016/S0021-9258(18)42682-8</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/1556128">1556128</a>.</li> <li>Yoshizumi M, Kourembanas S, Temizer DH, et al. (1992). <a href="https://doi.org/10.1016%2FS0021-9258%2819%2950112-0">"Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells"</a>. <i>J. Biol. Chem</i>. 267 (14): 9467–9. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0021-9258%2819%2950112-0">10.1016/S0021-9258(19)50112-0</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/1577791">1577791</a>.</li> <li>Higashiyama S, Abraham JA, Miller J, et al. (1991). "A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF". <i>Science</i>. 251 (4996): 936–9. <a href="/facts/Bibcode_(identifier)/9HtdQSGB">Bibcode</a>:<a href="https://ui.adsabs.harvard.edu/abs/1991Sci...251..936H">1991Sci...251..936H</a>. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1126%2Fscience.1840698">10.1126/science.1840698</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/1840698">1840698</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:23639487">23639487</a>.</li> <li>Iwamoto R, Senoh H, Okada Y, et al. (1991). <a href="https://doi.org/10.1016%2FS0021-9258%2818%2954947-4">"An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor"</a>. <i>J. Biol. Chem</i>. 266 (30): 20463–9. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0021-9258%2818%2954947-4">10.1016/S0021-9258(18)54947-4</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/1939101">1939101</a>.</li> <li>Hayes H, Kaneda Y, Uchida T, Okada Y (1988). "Regional assignment of the gene for diphtheria toxin sensitivity using subchromosomal fragments in microcell hybrids". <i>Chromosoma</i>. 96 (1): 26–32. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1007%2FBF00285879">10.1007/BF00285879</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/3436221">3436221</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:35349033">35349033</a>.</li> <li>Bennett KL, Jackson DG, Simon JC, et al. (1995). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199889">"CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor"</a>. <i>J. Cell Biol</i>. 128 (4): 687–98. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1083%2Fjcb.128.4.687">10.1083/jcb.128.4.687</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199889">2199889</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/7532176">7532176</a>.</li> <li>Pathak BG, Gilbert DJ, Harrison CA, et al. (1995). <a href="https://zenodo.org/record/1229661">"Mouse chromosomal location of three EGF receptor ligands: amphiregulin (Areg), betacellulin (Btc), and heparin-binding EGF (Hegfl)"</a>. <i>Genomics</i>. 28 (1): 116–8. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1006%2Fgeno.1995.1116">10.1006/geno.1995.1116</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/7590736">7590736</a>.</li> <li>Mitamura T, Higashiyama S, Taniguchi N, et al. (1995). <a href="https://doi.org/10.1074%2Fjbc.270.3.1015">"Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity"</a>. <i>J. Biol. Chem</i>. 270 (3): 1015–9. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1074%2Fjbc.270.3.1015">10.1074/jbc.270.3.1015</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/7836353">7836353</a>.</li> <li>Hashimoto K, Higashiyama S, Asada H, et al. (1994). <a href="https://doi.org/10.1016%2FS0021-9258%2817%2932127-0">"Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes"</a>. <i>J. Biol. Chem</i>. 269 (31): 20060–6. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0021-9258%2817%2932127-0">10.1016/S0021-9258(17)32127-0</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8051092">8051092</a>.</li> <li>Kobrin MS, Funatomi H, Friess H, et al. (1994). "Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer". <i>Biochem. Biophys. Res. Commun</i>. 202 (3): 1705–9. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1006%2Fbbrc.1994.2131">10.1006/bbrc.1994.2131</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8060360">8060360</a>.</li> <li>Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". <i>Gene</i>. 138 (1–2): 171–4. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2F0378-1119%2894%2990802-8">10.1016/0378-1119(94)90802-8</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8125298">8125298</a>.</li> <li>Thompson SA, Higashiyama S, Wood K, et al. (1994). <a href="https://doi.org/10.1016%2FS0021-9258%2817%2941979-X">"Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin"</a>. <i>J. Biol. Chem</i>. 269 (4): 2541–9. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0021-9258%2817%2941979-X">10.1016/S0021-9258(17)41979-X</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8300582">8300582</a>.</li> <li>Fen Z, Dhadly MS, Yoshizumi M, et al. (1993). "Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor". <i>Biochemistry</i>. 32 (31): 7932–8. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1021%2Fbi00082a014">10.1021/bi00082a014</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/8347598">8347598</a>.</li> <li>Elenius K, Paul S, Allison G, et al. (1997). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1169725">"Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation"</a>. <i>EMBO J</i>. 16 (6): 1268–78. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1093%2Femboj%2F16.6.1268">10.1093/emboj/16.6.1268</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1169725">1169725</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/9135143">9135143</a>.</li> <li>Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". <i>Gene</i>. 200 (1–2): 149–56. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0378-1119%2897%2900411-3">10.1016/S0378-1119(97)00411-3</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/9373149">9373149</a>.</li> <li>Louie GV, Yang W, Bowman ME, Choe S (1998). <a href="https://doi.org/10.1016%2FS1097-2765%2800%2980008-8">"Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor"</a>. <i>Mol. Cell</i>. 1 (1): 67–78. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS1097-2765%2800%2980008-8">10.1016/S1097-2765(00)80008-8</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/9659904">9659904</a>.</li> <li>Borer JG, Park JM, Atala A, et al. (1999). "Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction". <i>Lab. Invest</i>. 79 (11): 1335–45. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/10576204">10576204</a>.</li> <li>Nakamura K, Mitamura T, Takahashi T, et al. (2000). <a href="https://doi.org/10.1074%2Fjbc.M907971199">"Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity"</a>. <i>J. Biol. Chem</i>. 275 (24): 18284–90. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1074%2Fjbc.M907971199">10.1074/jbc.M907971199</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/10749879">10749879</a>.</li> <li>Duque JL, Adam RM, Mullen JS, et al. (2001). "Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro". <i>J. Urol</i>. 165 (1): 284–8. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1097%2F00005392-200101000-00080">10.1097/00005392-200101000-00080</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/11125426">11125426</a>.</li> <li>Lin J, Hutchinson L, Gaston SM, et al. (2001). <a href="https://doi.org/10.1074%2Fjbc.M010237200">"BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation"</a>. <i>J. Biol. Chem</i>. 276 (32): 30127–32. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1074%2Fjbc.M010237200">10.1074/jbc.M010237200</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/11340068">11340068</a>.</li></ul> <h2 id="external-links">External links</h2> <ul><li><a href="https://meshb.nlm.nih.gov/record/ui?name=heparin-binding+EGF-like+growth+factor">heparin-binding EGF-like growth factor</a> at the U.S. National Library of Medicine <a href="/facts/Medical_Subject_Headings/C57g2JuF">Medical Subject Headings</a> (MeSH)</li></ul> <h2 id="references">References</h2> <ol> <li id="fn:1"><p>Nanba D, Higashiyama S (February 2004). "Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor". Cytokine Growth Factor Rev. 15 (1): 13–9. doi:10.1016/j.cytogfr.2003.10.002. PMID 14746810. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li> <li id="fn:2"><p>Jin K, Mao XO, Sun Y, Xie L, Jin L, Nishi E, Klagsbrun M, Greenberg DA (July 2002). "Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo". J. Neurosci. 22 (13): 5365–73. doi:10.1523/JNEUROSCI.22-13-05365.2002. PMC 6758221. PMID 12097488. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758221" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758221</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li> <li id="fn:3"><p>Raab G, Klagsbrun M (December 1997). "Heparin-binding EGF-like growth factor". Biochim. Biophys. Acta. 1333 (3): F179–99. doi:10.1016/S0304-419X(97)00024-3. PMID 9426203. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:3" class="footnote-back-ref">↩</a></p></li> <li id="fn:4"><p>Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M, Andrews GK, Dey SK (May 1994). "Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation". Development. 120 (5): 1071–83. doi:10.1242/dev.120.5.1071. PMID 8026321. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:4" class="footnote-back-ref">↩</a></p></li> <li id="fn:5"><p>Nishi E, Prat A, Hospital V, Elenius K, Klagsbrun M (July 2001). "N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration". EMBO J. 20 (13): 3342–50. doi:10.1093/emboj/20.13.3342. PMC 125525. PMID 11432822. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125525" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125525</a> <a href="#fnref:5" class="footnote-back-ref">↩</a></p></li> <li id="fn:6"><p>Nanba D, Mammoto A, Hashimoto K, Higashiyama S (November 2003). "Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF". J. Cell Biol. 163 (3): 489–502. doi:10.1083/jcb.200303017. PMC 2173632. PMID 14597771. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173632" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173632</a> <a href="#fnref:6" class="footnote-back-ref">↩</a></p></li> <li id="fn:7"><p>Nanba D, Toki F, Higashiyama S (July 2004). "Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF". Biochem. Biophys. Res. Commun. 320 (2): 376–82. doi:10.1016/j.bbrc.2004.05.176. PMID 15219838. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:7" class="footnote-back-ref">↩</a></p></li> <li id="fn:8"><p>Lin J, Hutchinson L, Gaston SM, Raab G, Freeman MR (August 2001). "BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation". J. Biol. Chem. 276 (32): 30127–32. doi:10.1074/jbc.M010237200. PMID 11340068. <a href="https://doi.org/10.1074%2Fjbc.M010237200" target="_blank">https://doi.org/10.1074%2Fjbc.M010237200</a> <a href="#fnref:8" class="footnote-back-ref">↩</a></p></li> <li id="fn:9"><p>Hospital V, Prat A (October 2004). "Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation". Protein Pept. Lett. 11 (5): 501–8. doi:10.2174/0929866043406508. PMID 15544571. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:9" class="footnote-back-ref">↩</a></p></li> <li id="fn:10"><p>Miyamoto S, Yagi H, Yotsumoto F, Kawarabayashi T, Mekada E (May 2006). "Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy". Cancer Sci. 97 (5): 341–7. doi:10.1111/j.1349-7006.2006.00188.x. PMC 11159358. PMID 16630129. S2CID 32160328. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11159358" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11159358</a> <a href="#fnref:10" class="footnote-back-ref">↩</a></p></li> <li id="fn:11"><p>Nolan TM, Di Girolamo N, Coroneo MT, Wakefield D (January 2004). "Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts". Invest. Ophthalmol. Vis. Sci. 45 (1): 110–3. doi:10.1167/iovs.03-0046. PMID 14691161. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:11" class="footnote-back-ref">↩</a></p></li> <li id="fn:12"><p>Miyazono K (January 2012). "Ectodomain shedding of HB-EGF: a potential target for cancer therapy". J. Biochem. 151 (1): 1–3. doi:10.1093/jb/mvr120. PMID 21976708. <a href="https://doi.org/10.1093%2Fjb%2Fmvr120" target="_blank">https://doi.org/10.1093%2Fjb%2Fmvr120</a> <a href="#fnref:12" class="footnote-back-ref">↩</a></p></li> <li id="fn:13"><p>Iwamoto R, Mekada E (2006). "ErbB and HB-EGF signaling in heart development and function". Cell Struct. Funct. 31 (1): 1–14. doi:10.1247/csf.31.1. PMID 16508205. <a href="https://doi.org/10.1247%2Fcsf.31.1" target="_blank">https://doi.org/10.1247%2Fcsf.31.1</a> <a href="#fnref:13" class="footnote-back-ref">↩</a></p></li> <li id="fn:14"><p>Zhang H, Sunnarborg SW, McNaughton KK, Johns TG, Lee DC, Faber JE (May 2008). "Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodeling". Circ. Res. 102 (10): 1275–85. doi:10.1161/CIRCRESAHA.108.171728. PMC 2752633. PMID 18436796. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752633" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752633</a> <a href="#fnref:14" class="footnote-back-ref">↩</a></p></li> <li id="fn:15"><p>Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C, Yokota K, Nakamura M, Sayama K, Mekada E, Higashiyama S, Hashimoto K (June 2005). "Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing". J. Cell Sci. 118 (Pt 11): 2363–70. doi:10.1242/jcs.02346. PMID 15923649. S2CID 17496049. <a href="/wiki/Doi_(identifier)" target="_blank">/wiki/Doi_(identifier)</a> <a href="#fnref:15" class="footnote-back-ref">↩</a></p></li> <li id="fn:16"><p>Marikovsky M, Breuing K, Liu PY, Eriksson E, Higashiyama S, Farber P, Abraham J, Klagsbrun M (May 1993). "Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury". Proc. Natl. Acad. Sci. U.S.A. 90 (9): 3889–93. Bibcode:1993PNAS...90.3889M. doi:10.1073/pnas.90.9.3889. PMC 46411. PMID 8483908. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC46411" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC46411</a> <a href="#fnref:16" class="footnote-back-ref">↩</a></p></li> <li id="fn:17"><p>Jin K, Mao XO, Sun Y, Xie L, Jin L, Nishi E, Klagsbrun M, Greenberg DA (July 2002). "Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo". J. Neurosci. 22 (13): 5365–73. doi:10.1523/JNEUROSCI.22-13-05365.2002. PMC 6758221. PMID 12097488. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758221" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758221</a> <a href="#fnref:17" class="footnote-back-ref">↩</a></p></li> <li id="fn:18"><p>Leach RE, Khalifa R, Armant DR, Brudney A, Das SK, Dey SK, Fazleabas AT (September 2001). "Heparin-binding EGF-like growth factor modulation by antiprogestin and CG in the baboon (Papio anubis)". J. Clin. Endocrinol. Metab. 86 (9): 4520–8. doi:10.1210/jcem.86.9.7835. PMID 11549702. <a href="https://doi.org/10.1210%2Fjcem.86.9.7835" target="_blank">https://doi.org/10.1210%2Fjcem.86.9.7835</a> <a href="#fnref:18" class="footnote-back-ref">↩</a></p></li> <li id="fn:19"><p>Chen CL, Yu X, James IO, Zhang HY, Yang J, Radulescu A, Zhou Y, Besner GE (March 2012). "Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis". Lab. Invest. 92 (3): 331–44. doi:10.1038/labinvest.2011.167. PMC 3289750. PMID 22157721. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289750" target="_blank">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289750</a> <a href="#fnref:19" class="footnote-back-ref">↩</a></p></li> <li id="fn:20"><p>Fukatsu Y, Noguchi T, Hosooka T, Ogura T, Kotani K, Abe T, Shibakusa T, Inoue K, Sakai M, Tobimatsu K, Inagaki K, Yoshioka T, Matsuo M, Nakae J, Matsuki Y, Hiramatsu R, Kaku K, Okamura H, Fushiki T, Kasuga M (June 2009). "Muscle-specific overexpression of heparin-binding epidermal growth factor-like growth factor increases peripheral glucose disposal and insulin sensitivity". Endocrinology. 150 (6): 2683–91. doi:10.1210/en.2008-1647. PMID 19264873. <a href="https://doi.org/10.1210%2Fen.2008-1647" target="_blank">https://doi.org/10.1210%2Fen.2008-1647</a> <a href="#fnref:20" class="footnote-back-ref">↩</a></p></li> </ol>